Article

RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Octreotide-LAR is a Useful Alternative for the Management of Diazoxide-Responsive Congenital Hyperinsulinism.

Keywords : ['diazoxideresponsive congenital hyperinsulinism', 'useful alternative', 'octreotidelar', 'management']
Author : MP Karlekar
64

Octreotide-LAR is a Useful Alternative for the Management of Diazoxide-Responsive Congenital Hyperinsulinism.

Keywords : ['diazoxideresponsive congenital hyperinsulinism', 'useful alternative', 'octreotidelar', 'management']
Author : MP Karlekar
65

Octreotide-LAR is a Useful Alternative for the Management of Diazoxide-Responsive Congenital Hyperinsulinism.

Keywords : ['diazoxideresponsive congenital hyperinsulinism', 'useful alternative', 'octreotidelar', 'management']
Author : MP Karlekar
64

Clinical efficacy and safety of dasiglucagon in severe hypoglycemia associated with patients of type 1 diabetes mellitus: a systematic review and meta-analysis.

Keywords : ['type diabetes mellitus', 'severe hypoglycemia associate', 'systematic review', 'clinical efficacy', 'safety', 'patient', 'metaanalysis', 'dasiglucagon']
Author : S Dholariya
375

Clinical efficacy and safety of dasiglucagon in severe hypoglycemia associated with patients of type 1 diabetes mellitus: a systematic review and meta-analysis.

Keywords : ['type diabetes mellitus', 'severe hypoglycemia associate', 'systematic review', 'clinical efficacy', 'safety', 'patient', 'metaanalysis', 'dasiglucagon']
Author : S Dholariya
361

Clinical efficacy and safety of dasiglucagon in severe hypoglycemia associated with patients of type 1 diabetes mellitus: a systematic review and meta-analysis.

Keywords : ['type diabetes mellitus', 'severe hypoglycemia associate', 'systematic review', 'clinical efficacy', 'safety', 'patient', 'metaanalysis', 'dasiglucagon']
Author : S Dholariya
423

Is Hypoglycemia Secondary to Metastatic Retroperitoneal Sarcoma - A Therapeutic Challenge? Case Report and Review of Literature.

Keywords : ['therapeutic challenge case report', 'metastatic retroperitoneal sarcoma', 'hypoglycemia secondary', 'review', 'literature']
Author : RP Nair
245

Total Products : 2096873

Go to Page :

Have a Question?

Octreotide-LAR is a Useful Alternative for the Management of Diazoxide-Responsive Congenital Hyperinsulinism.

Octreotide-LAR is a Useful Alternative for the Management of Diazoxide-Responsive Congenital Hyperinsulinism.

Octreotide-LAR is a Useful Alternative for the Management of Diazoxide-Responsive Congenital Hyperinsulinism.

Clinical efficacy and safety of dasiglucagon in severe hypoglycemia associated with patients of type 1 diabetes mellitus: a systematic review and meta-analysis.

Clinical efficacy and safety of dasiglucagon in severe hypoglycemia associated with patients of type 1 diabetes mellitus: a systematic review and meta-analysis.

Clinical efficacy and safety of dasiglucagon in severe hypoglycemia associated with patients of type 1 diabetes mellitus: a systematic review and meta-analysis.

Is Hypoglycemia Secondary to Metastatic Retroperitoneal Sarcoma - A Therapeutic Challenge? Case Report and Review of Literature.

A novel mutation in the KCNJ11 gene (p.Val36Glu), predisposes to congenital hyperinsulinemia.

A novel mutation in the KCNJ11 gene (p.Val36Glu), predisposes to congenital hyperinsulinemia.

A novel mutation in the KCNJ11 gene (p.Val36Glu), predisposes to congenital hyperinsulinemia.